Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 22.00 GBp
Change Today 0.00 / 0.00%
Volume 27.2K
As of 11:35 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

venn life sciences holdings (VENN) Snapshot

Open
22.00 GBp
Previous Close
22.00 GBp
Day High
22.00 GBp
Day Low
22.00 GBp
52 Week High
01/26/15 - 26.25 GBp
52 Week Low
12/22/14 - 15.50 GBp
Market Cap
8.6M
Average Volume 10 Days
34.7K
EPS TTM
-0.06 GBp
Shares Outstanding
39.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VENN LIFE SCIENCES HOLDINGS (VENN)

Related News

No related news articles were found.

venn life sciences holdings (VENN) Related Businessweek News

No Related Businessweek News Found

venn life sciences holdings (VENN) Details

Venn Life Sciences Holdings plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations in France, Germany, the Netherlands, the United Kingdom, and Ireland. It offers a range of clinical trial services, including protocol development, feasibility and site selection, investigator and site selection, EC and regulatory submissions, project management, site management and monitoring, vendor management, quality assurance, training, IDMC management, consulting services, IVRS/IWRS, electronic data capture, data management, biostatistics, medical writing, pharmacovigilance, resourcing and recruitment, and investigator initiated studies. The company was founded in 2012 and is headquartered in Dublin, Ireland.

80 Employees
Last Reported Date: 05/29/15
Founded in 2012

venn life sciences holdings (VENN) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

venn life sciences holdings (VENN) Key Developments

Venn Life Sciences Holdings plc Appoints Jonathan Hartshorn as Chief Financial Officer

Venn Life Sciences Holdings plc announced the appointment of Jonathan Hartshorn as Chief Financial Officer with effect from June 15, 2015.

Venn Life Sciences Signs EUR 2 Million Contract with European Biotechnology Company

Venn Life Sciences announced the signing of a €2 million contract with a European Biotechnology company. The Phase III study, in the area of Rheumatology, will cover multiple European countries, commences immediately and will run over 4 years with a high concentration of activity in year one. The company has extensive experience in the management of Phase III trials with an excellent track record of multi-site and multi-cultural clinical trials.

Venn Life Sciences Holdings plc Announces Audited Consolidated Final Financial Results for the Year Ended 31 December 2014

Venn Life Sciences Holdings plc announced audited consolidated final financial results for the year ended 31 December 2014. For the year, revenue was €4,883,000 against €2,035,000 for the last year. Operating loss was €1,767,000 against €1,794,000 for the last year. EBITDA before exceptional items was €1,533,000 against €1,645,000 for the last year. Loss before income tax was €1,829,000 against €1,823,000 for the last year. Loss attributable to owners of the parent was €1,533,000 against €1,800,000 for the last year. Loss per ordinary basic and diluted share was €0.06 against €0.09 for the last year. Net cash used in operating activities was €1,028,000 against €1,859,000 for the last year. Purchase of property, plant and equipment was €99,000 against €31,000 for the last year. Losses in 2014 are principally attributable to the time lag between building a resource base and securing the necessary work to utilise the resource pool.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VENN:LN 22.00 GBp 0.00

VENN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VENN.
View Industry Companies
 

Industry Analysis

VENN

Industry Average

Valuation VENN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.7x
Price/Book 6.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VENN LIFE SCIENCES HOLDINGS, please visit www.vennlifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.